Literature DB >> 25663381

O-linked β-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension.

Jarrod W Barnes1, Liping Tian1, Gustavo A Heresi1, Carol F Farver1, Kewal Asosingh1, Suzy A A Comhair1, Kulwant S Aulak1, Raed A Dweik2.   

Abstract

BACKGROUND: Idiopathic pulmonary arterial hypertension (IPAH) is a cardiopulmonary disease characterized by cellular proliferation and vascular remodeling. A more recently recognized characteristic of the disease is the dysregulation of glucose metabolism. The primary link between altered glucose metabolism and cell proliferation in IPAH has not been elucidated. We aimed to determine the relationship between glucose metabolism and smooth muscle cell proliferation in IPAH. METHODS AND
RESULTS: Human IPAH and control patient lung tissues and pulmonary artery smooth muscle cells (PASMCs) were used to analyze a specific pathway of glucose metabolism, the hexosamine biosynthetic pathway. We measured the levels of O-linked β-N-acetylglucosamine modification, O-linked β-N-acetylglucosamine transferase (OGT), and O-linked β-N-acetylglucosamine hydrolase in control and IPAH cells and tissues. Our data suggest that the activation of the hexosamine biosynthetic pathway directly increased OGT levels and activity, triggering changes in glycosylation and PASMC proliferation. Partial knockdown of OGT in IPAH PASMCs resulted in reduced global O-linked β-N-acetylglucosamine modification levels and abrogated PASMC proliferation. The increased proliferation observed in IPAH PASMCs was directly impacted by proteolytic activation of the cell cycle regulator, host cell factor-1.
CONCLUSIONS: Our data demonstrate that hexosamine biosynthetic pathway flux is increased in IPAH and drives OGT-facilitated PASMC proliferation through specific proteolysis and direct activation of host cell factor-1. These findings establish a novel regulatory role for OGT in IPAH, shed a new light on our understanding of the disease pathobiology, and provide opportunities to design novel therapeutic strategies for IPAH.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferase; biosynthetic pathways; hexosamines; host cell factor C1; pulmonary hypertension; smooth muscle

Mesh:

Substances:

Year:  2015        PMID: 25663381      PMCID: PMC4390469          DOI: 10.1161/CIRCULATIONAHA.114.013878

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  54 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells.

Authors:  Natasha E Zachara; Niall O'Donnell; Win D Cheung; Jessica J Mercer; Jamey D Marth; Gerald W Hart
Journal:  J Biol Chem       Date:  2004-05-11       Impact factor: 5.157

Review 3.  The genetics of pulmonary arterial hypertension.

Authors:  Eric D Austin; James E Loyd
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

4.  Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.

Authors:  Y Gao; L Wells; F I Comer; G J Parker; G W Hart
Journal:  J Biol Chem       Date:  2001-01-08       Impact factor: 5.157

5.  Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.

Authors:  Keith Vosseller; Lance Wells; M Daniel Lane; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 6.  The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression.

Authors:  Rodrigo Diaz-Ruiz; Michel Rigoulet; Anne Devin
Journal:  Biochim Biophys Acta       Date:  2010-09-08

7.  Glycosylation of the c-Myc transactivation domain.

Authors:  T Y Chou; C V Dang; G W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

8.  The GLUT-1 XbaI gene polymorphism is associated with vascular calcifications in nondiabetic uremic patients.

Authors:  Margarita Rufino; Domingo Hernández; Ysamar Barrios; Eduardo Salido
Journal:  Nephron Clin Pract       Date:  2008-03-03

9.  High levels of hyaluronan in idiopathic pulmonary arterial hypertension.

Authors:  Metin Aytekin; Suzy A A Comhair; Carol de la Motte; Sudip K Bandyopadhyay; Carol F Farver; Vincent C Hascall; Serpil C Erzurum; Raed A Dweik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-09-05       Impact factor: 5.464

10.  Hepatic glucose sensing via the CREB coactivator CRTC2.

Authors:  Renaud Dentin; Susan Hedrick; Jianxin Xie; John Yates; Marc Montminy
Journal:  Science       Date:  2008-03-07       Impact factor: 47.728

View more
  30 in total

1.  O-GlcNAcylation reduces proximal tubule protein reabsorption and promotes proteinuria in spontaneously hypertensive rats.

Authors:  Rodrigo Pacheco Silva-Aguiar; Nathália C F Bezerra; Miguel C Lucena; Gabriela M Sirtoli; Roberto T Sudo; Gisele Zapata-Sudo; Christina M Takiya; Ana Acacia S Pinheiro; Wagner Barbosa Dias; Celso Caruso-Neves
Journal:  J Biol Chem       Date:  2018-06-28       Impact factor: 5.157

2.  Pulmonary Hypertension and Precision Medicine through the "Omics" Looking Glass.

Authors:  Jarrod W Barnes; Raed A Dweik
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

3.  Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein O-GlcNAc Modification.

Authors:  Yabing Chen; Xinyang Zhao; Hui Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-29       Impact factor: 8.311

4.  Abnormal Glucose Metabolism and High-Energy Expenditure in Idiopathic Pulmonary Arterial Hypertension.

Authors:  Gustavo A Heresi; Steven K Malin; Jarrod W Barnes; Liping Tian; John P Kirwan; Raed A Dweik
Journal:  Ann Am Thorac Soc       Date:  2017-02

Review 5.  Novel methods in pulmonary hypertension phenotyping in the age of precision medicine (2015 Grover Conference series).

Authors:  Jarrod W Barnes; Adriano R Tonelli; Gustavo A Heresi; Jennie E Newman; Noël E Mellor; David E Grove; Raed A Dweik
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

6.  Metabolomics of exercise pulmonary hypertension are intermediate between controls and patients with pulmonary arterial hypertension.

Authors:  Jason L Sanders; Yuchi Han; Mariana F Urbina; David M Systrom; Aaron B Waxman
Journal:  Pulm Circ       Date:  2019-10-30       Impact factor: 3.017

7.  Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension.

Authors:  Victor Tseng; Roy L Sutliff; C Michael Hart
Journal:  Antioxid Redox Signal       Date:  2019-02-25       Impact factor: 8.401

8.  Lipids and ketones dominate metabolism at the expense of glucose control in pulmonary arterial hypertension: a hyperglycaemic clamp and metabolomics study.

Authors:  Jacob T Mey; Adithya Hari; Christopher L Axelrod; Ciarán E Fealy; Melissa L Erickson; John P Kirwan; Raed A Dweik; Gustavo A Heresi
Journal:  Eur Respir J       Date:  2020-04-09       Impact factor: 16.671

9.  Things We "kNOw" and Do Not "kNOw" about Pulmonary Hypertension.

Authors:  Jarrod W Barnes; Rakesh P Patel
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

Review 10.  Critical observations that shaped our understanding of the function(s) of intracellular glycosylation (O-GlcNAc).

Authors:  Natasha E Zachara
Journal:  FEBS Lett       Date:  2018-11-24       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.